baber/WOPTO huggingface dataset:
Patent BR-PI0722030-B1 (BR)
Title: unidade de condicionamento de ar
Inventor: LUCIANO DA LUZ MORAES
IPC: F25D23/12
Filed: 2007-09-18
Abstract: unidade de condicionamento de ar é revelada uma unidade de condicionamento de ar que inclui uma armação que provê uma passagem de ar, tal como uma entrada de ar. um painel dianteiro cobre a passagem de ar durante operação de condicionamento de ar normal. uma articulação interconecta o painel dianteiro na armação e é configurado para prover posições rotacionais aberta e fechada do painel dianteiro em relação à armação. em um exemplo, o painel dianteiro inclui uma abertura pela qual um controle do usuário, tal como um botão, estende- se. o painel dianteiro pode ser rotacionado da posição fechada para a posição aberta sem remoção do botão. a armação e o painel dianteiro também incluem um engate para prender o painel dianteiro na armação na posição rotacional fechada.
Patent BR-PI0722418-B1 (BR)
Title: Processo para tratamento de biomassa lignocelulósica com vapores de amônia e de água
Inventor: BRUCE E DALE
IPC: C12P19/02
Filed: 2007-04-30
Abstract: processo para o tratamento de biomassa lignocelulósica, e sistema de pré-tratamento. a presente invenção refere-se a um processo e sistema para tratamento de biomassa, que compreende a adição de vapores de amônia e vapores de água, em uma temperatura elevada, a um vaso fechado contendo biomassa, assim que carboidratos estruturais na biomassa sejam tornados mais suscetíveis à hidrólise.
Patent BR-PI0816052-B1 (BR)
Title: motor de combustão interna do tipo de ignição por centelha
Inventor: YUKIHIRO NAKASAKA
IPC: F02D13/02
Filed: 2008-11-06
Abstract: motor de combustão interna do tipo de ignição por centelha a presente invenção refere-se a um motor de combustão interna, um mecanismo de relação de compressão variável (a) capaz de mudar uma relação de compressão mecânica, um mecanismo de sincronismo de válvula variável (8) capaz de controlar o sincronismo de fechamento de uma válvula de admissão (7), e um meio de predição para a predição da temperatura do catalisador disposto na passagem de exaustão de motor que são providos. quando é predito que a temperatura do catalisador cairá para menos do que a temperatura de ativação, a relação de expansão real é diminuída, enquanto se mantém a relação de compressão real a mesma ou enquanto se aumenta a relação de compressão real.
Patent BR-PI0915569-B1 (BR)
Title: inserto de corte alinhável, e, fresa
Inventor: ASSAF BALLAS
IPC: B23C5/10
Filed: 2009-06-28
Abstract: inserto de corte alinhável, e, fresa. um inserto de corte alinhável (20) e uma fresa (58; fig.5) com insertos de corte alinháveis idênticos (20). o inserto de corte alinhável (20) tem uma superfície superior (22), superfície superior oposta (24), e uma superfície lateral periférica (26). bordas de corte maiores (46,48) são formadas em uma borda periférica superior (28), com duas superfícies inclinadas adjacentes (54, 56) na superfície superior (22). pelo menos duas das bordas de corte maiores (46,48) têm diferentes ângulos de inclinação axiais de inserto (al, a2) em pontos de índice equivalentes (e,f) ao longo das bordas de corte maiores (46, 48), e pelo menos duas das superfícies inclinadas (54, 56) têm diferentes ângulos de perfil de superfície inclinada (b1, b2) em seções planas (p4,p5) que são perpendiculares às bordas de corte maiores (46, 48) e contêm um eixo de inserto (a, b). a fresa (58) tem um corpo de fresa (62) com uma pluralidade de cavidades de recepção de inserto idênticas (60), onde um número igual dos insertos de corte alinháveis idênticos (20) são removivelmente assentado, tendo ativo bordas de corte maiores (46,48) e ativo duas superfícies inclinadas (54, 56) com diferentes ângulos de inclinação axiais e/ou radiais.
Patent BR-PI1103791-B1 (BR)
Title: meios de cultura de resíduo de bagaço de laranja para produção simultânea das enzimas fitase e tanase pelo microorganismo paecilomyces variotii através de fermentação sólida, enzimas obtidas e seus usos
Inventor: GABRIELA ALVES MACEDO
IPC: C12N9/16
Filed: 2011-08-05
Abstract: MEIOS DE CULTURA DE RESÍDUO DE BAGAÇO DE LARANJA PARA PRODUÇÃO SIMULTÂNEA DAS ENZIMAS FITASE E TANASE PELO MICROORGANISMO PAECILOMYCES VARIOTII ATRAVÉS DE FERMENTAÇÃO SÓLIDA, ENZIMAS OBTIDAS E SEUS USOS. A presente invenção compreende a produção de meios de cultura capazes de viabilizar a produção simultânea de duas enzimas fitase e tanase através da fermentação sólida, em bagaço de laranja empregando o fungo Paecilomyces variotii. O uso de enzimas na alimentação animal é conhecido e está sendo bem explorado. A maior dificuldade de expandir o uso de enzimas ainda é o custo de produção. O uso dos resíduos para alimentação animal representa uma alternativa viável para este setor, assim como para a produção de biocatalizadores através da fermentação sólida. Dessa forma, o presente invento permite gue o bagaço de laranja apresente maior capacidade antioxidante em relação ao meio não fermentado, representando um ingrediente interessante para uso em ração animal. Esta invenção determinou valores ótimos na constituição do meio de cultura gue utiliza bagaço de laranja para produção das enzimas fitase e tanase através da fermentação sólida pelo microorganismo Paecilomyces variotii de forma a obter-se a maior guantidade de enzima produzida e suas maiores atividades. Adicionalmente, também foi determinada a (...).
Patent EA-001484-B1 (EA)
Title: Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluable vitamin e compound such as vitamin e-tpgs
Inventor: ROY ARUP K
IPC: A23L19/18
Filed: 1997-03-21
Abstract: 1. A pharmaceutical formulation for oral administration comprising a) 3S-[3R*(1R*, 2S*)]-[3-[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-(phenylmethyl)propyl]aminoformic acid tetrahydro-3-furanyl ester; b) a water soluble tocopherol derivative and (c) a hydrophilic non-aqueous solvent miscible with said water soluble tocopherol derivative wherein the ratio of (a) to (b) is from about 1:0.5 to about 1:10 w/w, wherein said (a), (b) and (c) intact in the formulation as fluctuating liquid. 2. A pharmaceutical formulation for oral administration comprising a) 3S-[3R*(1R*, 2S*)]-[3-[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-(phenylmethyl)propyl]aminoformic acid tetrahydro-3-furanyl ester in the amount of from 1% to 50% by weight in converting to total formulation weight; b) a water soluble tocopherol derivative in the amount of from 10% to 60% by weight in converting to total formulation weight; and (c) a hydrophilic non-aqueous solvent miscible with said water soluble tocopherol derivative in the amount of from 25% to 60% by weight in converting to total formulation weight; wherein said (a), (b) and (c) intact in the formulation as fluctuating liquid. 3. A pharmaceutical formulation according to claim 1 or 2 comprising at least 20% of a water soluble tocopherol derivative. 4. A pharmaceutical formulation as claimed in claim 1 or 2 wherein the ratio of (a) to (b) is from about 1:0.5 to about 1:1.3 w/w. 5. A pharmaceutical formulation as claimed in any preceding claims 1-4 wherein the water soluble tocopherol derivative is Vitamin E-TPGS. 6. A pharmaceutical formulation as claimed in any preceding claims 1-5 wherein a hydrophilic non-aqueous solvent is polyethyleneglycol, propyleneglycol or polyvinylpyrrolidone. 7. A pharmaceutical formulation for oral administration consisting a) 3S-[3R*(1R*, 2S*)]-[3-[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-(phenylmethyl)propyl]aminoformic acid tetrahydro-3-furanyl ester; (b) Vitamin E-TPGS; (c) polyethyleneglycol, and (d) propyleneglycol wherein said (a), (b) (c) and (d) intact in the formulation as fluctuating liquid. 8. A formulation as claimed in any preceding claim 1-7 present in the form of a capsule. 9. A formulation as claimed in any preceding claim 1-7 present in the form of a solution. 10. A method of preparing a formulation as claimed in any preceding claims 1-9 wherein 3S-[3R*(1R*, 2S*)]-[3-[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-(phenylmethyl)propyl]aminoformic acid tetrahydro-3-furanyl ester is dissolved in the mixture of water soluble tocopherol derivatives and hydrophilic non-aqueous solvent.
Patent EA-004648-B1 (EA)
Title: Pyrrolidinyl, piperidinyl or homopiperidinyl substituted derivatives, process for preparing thereof, use thereof in medicine, pharmaceutical composition containing them and method for its preparation
Inventor: DE BRUYN MARCEL FRANS LEOPOLD
IPC: C07D405/14
Filed: 2000-05-23
Abstract: 1. A compound of formula (I) a stereochemically isomeric form thereof, an N-oxide form thereof, a pharmaceutically acceptable acid addition salt thereof wherein R<1>, R<2> and R<3> are each H; -Z<1>-Z<2>- is a bivalent radical of formula -O-CH(R<4>)-CR2-CH2-			(a-4), R<4> is H; Alk is or C1-6alkanediyl optionally substituted with a hydroxy group; is a bivalent radical of formula wherein m is 0 or 1; R<6> is hydroxy, hydroxyC1-4alkyl or C1-4alkyloxy; R<11> is H; R<5> is a radical of formula X is O; R<7> is H or C1-6 6alkyl; Q is a bivalent radical of formula -CH2-CH2-CH2-	(e-2) 2. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically active amount of a compound as claimed in claim 1. 3. A process for preparing a pharmaceutical composition as claimed in claim 2 wherein a therapeutically active amount of a compound as claimed in claim 1 is intimately mixed with a pharmaceutically acceptable carrier. 4. A compound as claimed in claim 1 for use as a medicine. 5. A process for preparing a compound of formula (I) wherein an intermediate of formula (II) is alkylated with an intermediate of formula (III) in a reaction-inert solvent and, optionally in the presence of a suitable base wherein W is an appropriate leaving group, R<1>-R<3>, Z<1>, Z<2>, R<5>, Alk and are as defined in claim 1, and optionally either one resulted compound of formula (I) is converted into another compound of formula (I) following art-known transformation reactions; or if desired; a compound of formula (I) is converted into an acid addition salt, or conversely, an acid addition salt of a compound of formula(I) is converted into a free base form with alkali; and, if desired, preparing stereochemically isomeric forms thereof. 6. A process for preparing a compound of formula (IV) wherein an intermediate of formula (IV) wherein Alkl<1> represents a direct bond or C1-5alkanediyl, is reductively alkylated with an intermediate of formula (III) wherein the radicals -Z<1>-Z<2>-, R<1>, R<2>, R<3>, R<4>, R<5> and a divalent radical are as defined in claim 1, and optionally either one resulted compound of formula (I) is converted into another compound of formula (I) following art-known transformation reactions; or if desired; a compound of formula (I) is converted into an acid addition salt, or conversely, an acid addition salt of a compound of formula (I) is converted into a free base form with alkali; and, if desired, preparing stereochemically isomeric forms thereof.
Patent EA-012444-B1 (EA)
Title: Method for assessing ovarian reserve and predicting ovarian response and a kit therefor
Inventor: SEIFER DAVID B
IPC: G01N33/68
Filed: 2002-08-20
Abstract: Methods and kits are provided for assessing the ovarian reserve and predicting the ovarian response to fertility treatments in a female subject. The serum levels of MIS are shown to be positively correlated with the production and retrieval of mature oocytes and serve as prognostic indicators for the female response to fertility treatment. The MIS levels can be monitored prior to and during fertility treatment and are useful to adjust the timing and dosage of treatments in order to produce optimal outcome in individual patients, to avoid ovarian hyperstimulation, or to indicate cancellation of an unsuccessful treatment.
Patent EA-009352-B1 (EA)
Title: Method for attenuating noise in seismic data using complex trace diversity filter
Inventor: MARTIN FEDERICO D
IPC: G01V1/28
Filed: 2005-06-02
Abstract: A method is disclosed for attenuating noise in seismic data. The method includes calculating a trace envelope for at least part of at least one seismic trace, generating a filtered envelope from the trace envelope, and transforming the filtered envelope to a filtered trace. In one embodiment, a length of a filter operator used for generating the filtered envelope is inversely related to a maximum frequency to be preserved in the filtered trace.
Patent EA-011355-B1 (EA)
Title: Detection of lipid oxidising abzymes in samples
Inventor: PETYAEV IVAN
IPC: G01N33/68
Filed: 2006-02-24
Abstract: This invention relates to the finding that lipid oxidising abzymes damage Chlamydia antigens in a sample and the extent of damage provides a measure of the level or activity of the abzymes in the sample. Lipid oxidising abzymes may be measured or detected, for example, by abrogating or abolishing abzyme mediated lipid oxidation activity in a sample, and determining the binding of antibodies in the sample to a Chlamydia antigen relative to controls. Such methods may be useful in the assessment of cardiovascular conditions.
Patent EA-013651-B1 (EA)
Title: Apparatus for transporting, heating and laying thermoplastic materials
Inventor: PANASYUK ANATOLIJ IVANOVICH
IPC: E01C19/08
Filed: 2007-12-05
Abstract: The invention relates to road building and construction of roofs of buildings without attics. The proposed apparatus for transporting, heating and laying thermoplastic materials contains a frame with heat-insulated enclosure, fixed on the chassis of a vehicle, a semi-cylindrical capacity, placed in it and inclined to an unloading zone, with a loading gate and a cover above, with a discharge cock and a draining tray in the unloading zone, with a working shaft inside, located along a central axis and mounted in the bearings on the front and back end walls of the semi-cylindrical capacity, and also provided with the transversal mixing blades; a drive kinematically bonded with a transfer member on the working shaft; a heating system in the form of a chamber, located between the heat-insulated enclosure and a side circular wall of the semi-cylindrical capacity, with the chimneys on the outer surface of the chamber and with the burners inside placed into the flues; a sensor and a measuring instrument of the temperature of the heated thermoplastic material. The novelty is that the flues are made perforated from the side circular wall of the semi-cylindrical capacity, the chimneys are provided with the spring-loaded dampers fastened by the hinged connection, a bushing for placing the sensor of the temperature is mounted in the immediate vicinity of the discharge cock, the transfer member on the working shaft is made heat-insulated, the working shaft is made tubular with the possibility of providing the entry of a heat carrier into its inner cavity and also performing a function of a radiator jointly with the transversal mixing blades, the radiator sends heat energy additionally through the centre radially towards entering heat energy from the side circular wall of the semi-cylindrical capacity, and one end of the tubular working shaft is connected to the chamber of the heating system through a Λ-shaped heat-insulated tubing fastened on the back end wall, and the other end is connected to the atmosphere through a heat-insulated discharge flue fastened on a post before the front end wall and provided with a draft damper of heated gases. Aforesaid improvements make it possible to reduce heat energy leaks considerably, to accelerate the achievement of the required heating temperature of the thermoplastic materials with simultaneous reduction of the fuel consumption in the burners of the heating system, to reduce time losses and to increase productivity, and also make it possible to provide the possibility for independent preparing the thermoplastic materials directly on the proposed apparatus, to expand its functional and technological capabilities and application fields.
Patent EA-014691-B1 (EA)
Title: A process for the preparation of sartan derivatives and intermediates useful in such process
Inventor: VEVERKA MIROSLAV
IPC: C07D233/54
Filed: 2006-09-20
Abstract: The invention provides a process for the preparation of a sartan derivative of formula (I) (formula as filed in paper form) (I) wherein the substituents have the meaning indicated in the description, or a pharmaceutically acceptable salt thereof, comprising reacting 2-cyanophenylboronic acid or a derivative thereof with a p-halobenzyl-1H-imidazole derivative of formula (VI), (formula as filed in paper form) (VI) wherein (part of formula as filed in paper form), X, Y, R1 and Rare as defined above, and Z is I, Br or Cl, in the presence of a transition metal catalyst and an inorganic or organic base. The invention also provides new intermediates of formula (V), (formula as filed in paper form) (V) wherein M is an alkali metal or an NRRRRgroup; and of formula (II) (formula as filed in paper form).
Patent EA-012292-B1 (EA)
Title: Dosage system to a static mixer and method for controlling thereof
Inventor: ROBERGE DOMINIGUE
IPC: G01F23/20
Filed: 2006-10-23
Abstract: A dosage system for feeding a fluid (A) to a static mixer (1), said system comprising a tank (2) containing said fluid (A) at a predetermined pressure, a fluid passage (3) connecting said container (1) and tank (2), a control valve (4) provided within said fluid passage (3) to control the flow of said fluid (A) from said tank into said container; and a controller (6) for receiving a target flow rate (SP_Q) of said fluid (A), and an actual flow rate (PV_Q) of said fluid (A), and for outpurting a control signal (MV_L) to said control valve (4) indicating a valve position to adjust the flow rate. Further provided is a method for controlling said dosage system.
Patent EA-016513-B1 (EA)
Title: System and method for marine seismic surveying
Inventor: TENGHAMN STIG RUNE LENNART
IPC: G01V1/20
Filed: 2008-04-10
Abstract: A system for marine seismic surveying comprises at least one marine seismic streamer; at least one pressure sensor mounted in the at least one marine seismic streamer; at least one particle motion sensor mounted in the at least one marine seismic streamer and collocated with the at least one pressure sensor, wherein the at least one particle motion sensor has a resonance frequency above 20 Hz; and computer means for combining pressure data from the at least one pressure sensor and particle motion data from the at least one particle motion sensor for further processing
Patent EA-021447-B1 (EA)
Title: Starch pre-dispersion preparation system and method for gypsum board production
Inventor: YU QIANG
IPC: E04C2/26
Filed: 2009-08-28
Abstract: The present invention provides a wet starch preparation system for gypsum wallboard comprising a loss-in-weight starch feeder, a Venturi mixer, a vacuum pick-up unit for supplying the dry starch from the feeder at an adjustable rate to the Venturi mixer, a first water pump for supplying water at an adjustable rate to the Venturi mixer to form a starch pre-dispersion of from about 2 to about 10% by weight starch and a second water pump for supplying gauging water to the starch pre-dispersion, the system equipped with appropriate system controls. The present system provides more efficient use of starch such that the amount of pregelatinized starch is at least about 10% less than a system in which the starch is not pre-dispersed in water prior to the board mixer. The system can be used to make gypsum-containing products including gypsum wallboard having increased board strength and reduced board weight.
Patent EA-022715-B1 (EA)
Title: Pharmaceutical composition for treatment of essential thrombocythemia
Inventor: WIDMANN RUDOLF
IPC: A61K47/10
Filed: 2009-12-04
Abstract: The invention relates to novel formulations of anagrelide resulting in a non-immediate release of the active ingredient of anagrelide. The inventors have shown that pharmaceutical compositions comprising anagrelide particles, wherein at least 90% of said anagrelide particles are smaller than 10 μm, in combination with lactose monohydrate provide a formulation with reduced release characteristics when administered to a patient. Optionally, the pharmaceutical composition can further comprise povidone, crospovidone, microcristalline cellulose and/or magnesium stearate.
Patent EA-028676-B1 (EA)
Title: Compacted moxifloxacin
Inventor: SWATSCHEK DIETER
IPC: A61K31/496
Filed: 2009-12-04
Abstract: The invention relates to a method for producing tablets containing moxifloxacin, comprising the steps of (i) providing moxifloxacin, pharmaceutically acceptable salts, solvates or hydrates thereof, optionally in a mixture with one or more pharmaceutical adjuvants; (ii) compacting into a slug; (iii) granulating the slug; and (iv) compressing the resulting granules into tablets, and to tablets, granules and slugs containing compacted moxifloxacin.
Patent EA-023270-B1 (EA)
Title: Granular savoury food concentrate and process to produce the same
Inventor: BUECKER BERND
IPC: A23L27/00
Filed: 2010-12-02
Abstract: A granular savoury food concentrate comprising from 10 to 65 wt.% of salt, from 1 to 20 wt.% of yeast extract and from 10 to 50 wt.% of flour, starch or a mixture thereof, wherein the granular food concentrate is not in a glassy state.
Patent EA-021591-B1 (EA)
Title: Device for wetting a bulk good
Inventor: DIKTY MARIO
IPC: F16L55/24
Filed: 2010-01-19
Abstract: The invention relates to a device for wetting a bulk good, in particular for moistening power plant filter ashes. The device comprises a downpipe. An inlet, through which the bulk good enters the downpipe, is formed at the upper end of the downpipe. An outlet, through which the bulk good is discharged in the wetted state, is formed at the lower end of the downpipe. A water supply to the downpipe is provided, and the downpipe has a flexible wall section.
Patent EA-023020-B1 (EA)
Title: SPIROHETEROCYCLIC COMPOUNDS AND USE THEREOF AS mGlu5 ANTAGONISTS
Inventor: LEONARDI AMEDEO
IPC: C07D498/10
Filed: 2011-07-08
Abstract: The invention provides compounds having the general formula (I)wherein X is an oxygen atom; Ris a carbon, nitrogen, oxygen or sulphur atom; Ris CH, CH, N or NH; Ris a valence bond or a CH or CHgroup; m is 1, 2 or 3; n is 1 or 2; when n is 2 or m is 2 or 3, the ring containing Rmay be fused with an optionally substituted benzene ring; and each — represents a single or double bond provided that one double bond extends from the carbon atom to which R-C≡C- is bonded and that no ring carbon atom bears two double bonds; and R, Rand Rrepresent a wide range of substituents. The present invention further provides development of a pharmaceutical composition for treating diseases or disorders of the lower urinary tract, migraine, gastroesophageal reflux disease, anxiety disorders, abuse, substance dependence and substance withdrawal disorders, neuropathic pain, and fragile X syndrome disorders, comprising the compound of formula I or a hydrate, enantiomer, diastereomer or pharmaceutically acceptable salts thereof in admixture with a pharmaceutically acceptable carrier.
Patent EA-019980-B1 (EA)
Title: BICYCLIC THIAZOLES AS ALLOSTERIC MODULATORS OF mGluR5 RECEPTORS
Inventor: MACDONALD GREGOR JAMES
IPC: A61K31/428
Filed: 2010-12-16
Abstract: The present invention relates to novel bicyclic thiazoles of formula (I) which are positive allosteric modulators of the metabotropic glutamate receptor subtype 5 ("mGluR5") and which are useful for the treatment or prevention of disorders associated with glutamate dysfunction and diseases in which the mGluR5 subtype of receptors is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which mGluR5 is involved.